Last updated on July 2019

Efficacy Safety and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia


Brief description of study

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786, as compared with placebo, for the treatment of negative symptoms of schizophrenia.

Clinical Study Identifier: NCT03896945

Find a site near you

Start Over

Clinical Research Site

Little Rock, AR United States
  Connect »

Clinical Research Site

Bellflower, CA United States
  Connect »

Clinical Research Site

Culver City, CA United States
  Connect »

Clinical Research Site

Garden Grove, CA United States
  Connect »

Clinical Research Site

Glendale, CA United States
  Connect »

Clinical Research Site

Lemon Grove, CA United States
  Connect »

Clinical Research Site

Oakland, CA United States
  Connect »

Clinical Research Site

Oceanside, CA United States
  Connect »

Clinical Research Site

Panorama City, CA United States
  Connect »

Clinical Research Site

Riverside, CA United States
  Connect »

Clinical Research Site

San Diego, CA United States
  Connect »

Clinical Research Site

Torrance, CA United States
  Connect »

Clinical Research Site

Largo, FL United States
  Connect »

Clinical Research Site

Miami, FL United States
  Connect »

Clinical Research Site

Atlanta, GA United States
  Connect »

Clinical Research Site

Lake Charles, LA United States
  Connect »

Clinical Research Site

Boston, MA United States
  Connect »

Clinical Research Site

Olivette, MO United States
  Connect »

Clinical Research Site

Saint Charles, MO United States
  Connect »

Clinical Research Site

Saint Louis, MO United States
  Connect »

Clinical Research Site

Berlin, NJ United States
  Connect »

Clinical Research Site

Jamaica, NY United States
  Connect »

Clinical Research Site

New York, NY United States
  Connect »

Clinical Research Site

Rochester, NY United States
  Connect »

Clinical Research Site

Richardson, TX United States
  Connect »